Chronic Lymphocytic Leukemia

	12/10/2009	Skin Cancers Observed More Frequently in Patients With CLL Than in General Population: Presented at ASH - (DGDispatch)
	10/27/2009	FDA Grants Accelerated Approval to Ofatumumab for Refractory Chronic Lymphocytic Leukaemia - (DGNews)
	09/03/2009	Rituximab Approved in Europe for Patients With Previously-Treated CLL - (DGNews)
	08/17/2009	Rituximab Plus Chemotherapy Approved in Canada for Previously Untreated CLL - (DGNews)
	07/24/2009	NICE Issues Final Guidance on the Use of Rituximab as First-Line Treatment of CLL - (DGNews)
	06/09/2009	Significant Survival Benefit From Adding Oblimersen to Fludarabine-Cyclophosphamide Combination Therapy in Relapsed/Refractory Chronic Lymphocytic Leukaemia: Presented at EHA - (DGDispatch)
	06/06/2009	Bendamustine Provides Benefit Over Chlorambucil for Patients With Chronic Lymphocytic Leukaemia: Presented at EHA - (DGDispatch)
	02/27/2009	Rituximab Approved in EU for Chronic Lymphocytic Leukaemia - (DGNews)
	02/16/2009	B-cell clones as early markers for chronic lymphocytic leukemia (N Engl J Med)
	02/12/2009	Abnormal B-Cells Found in Blood of CLL Patients Years Before Actual Diagnosis - (DGNews)
	01/02/2009	Inhibition of the Bcl-xL Deamidation Pathway in Myeloproliferative Disorders (N Engl J Med)
	12/19/2008	Combining 3 Infection Control Measures Reduces Mortality in High-Risk Cancer Patients - (DGNews)
	12/19/2008	FDA Approves Oral Formation of Fludarabine for Chronic Lymphocytic Leukaemia - (DGNews)
	12/16/2008	Pre-Existing Diabetes in Persons Diagnosed With Cancer Associated With Increased Risk of Death - (DGNews)
	12/11/2008	Single-Agent Ofatumumab Produces Response in Treatment-Refractory Chronic Lymphocytic Leukaemia: Presented at ASH - (DGDispatch)
	12/10/2008	Adding Rituximab to Combination Therapy Benefits Patients With Relapsed/Refractory Chronic Lymphocytic Leukaemia: Presented at ASH - (DGDispatch)
	12/09/2008	Cladribine Effective in Combination Therapy for Treating Chronic Lymphocytic Leukaemia: Presented at ASH - (DGDispatch)
	12/08/2008	Bendamustine Effective as First-Line Treatment in B-Cell Chronic Lymphocytic Leukaemia: Presented at ASH - (DGDispatch)
	12/07/2008	Adding Rituximab to Fludarabine and Cyclophosphamide Improves Outcomes in Chronic Lymphocytic Leukaemia: Presented at ASH - (DGDispatch)
	11/27/2008	Annual Report Finds Declines in Cancer Incidence and Death in US, But Wide Variation in Lung Cancer Trends - (DGNews)
	11/21/2008	Infection-Related Deaths Reported With Alemtuzumab, Warns Health Canada - (DGNews)
	11/06/2008	Predictive Biomarkers, Early Treatment May Delay Progression of CLL - (DGNews)
	10/28/2008	Invasive Pneumococcal Disease Occurs At a Higher Frequency in Cancer Patients: Presented at ICAAC/IDSA - (DGDispatch)
	09/15/2008	FDA Approves Granisetron Patch for Chemotherapy-Induced Nausea, Vomiting - (DGNews)
	09/14/2008	Aprepitant Effective Antiemetic in Cancer Patients Regardless of Nausea Risk Factors: Presented at ESMO - (DGDispatch)
	09/09/2008	Many Cancer Patients Receive Insufficient Pain Management Therapy - (DGNews)
	08/21/2008	FDA Investigating Possible Link Between Ezetimibe/Simvastatin and Increased Cancer Risk - (DGNews)
	08/11/2008	Intrabone Injection of Unrelated Cord-Blood Cells Prevents Graft Failure, Aids Haemopoietic Recovery - (DGNews)
	08/11/2008	Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia (N Engl J Med)
	07/31/2008	FDA Clears the Pathwork Tissue of Origin Test - (DGNews)